首页|期刊导航|中国中药杂志|基于TLR4/MAPK/NF-κB信号通路探讨橘红胎标准汤剂对急性肺损伤的保护作用

基于TLR4/MAPK/NF-κB信号通路探讨橘红胎标准汤剂对急性肺损伤的保护作用OA

Protective effects of Juhongtai standard decoction against acute lung injury via TLR4/MAPK/NF-κB signaling pathway

中文摘要英文摘要

探讨橘红胎标准汤剂对脂多糖(LPS)诱导的急性肺损伤(ALI)的保护作用及其机制.体内实验中,腹腔注射 5 mg·kg-1 LPS诱导SD大鼠ALI模型,设空白组,模型组,地塞米松组(0.315 mg·kg-1),橘红胎标准汤剂高(3.15 g·kg-1)、中(1.575 g·kg-1)、低(0.787 5 g·kg-1)剂量组.检测肺组织湿干重比(W/D)、髓过氧化酶(MPO)活性、超氧化物歧化酶(SOD)活性、血清一氧化氮(NO)水平;苏木素-伊红(HE)染色观察肺组织病理变化并进行肺泡腔面积占总面积比(PAA)评分;酶联免疫吸附测定(ELISA)检测血清中肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β含量;实时荧光定量PCR(RT-qPCR)检测肺组织中IL-1β、诱导型一氧化氮合酶(iNOS)mRNA表达;免疫组化与蛋白免疫印迹法(Western blot)检测Toll样受体 4(TLR4)、基质金属蛋白酶 9(MMP9)蛋白表达及核因子-κB抑制蛋白(IκB)、p65 核因子-κB(p65 NF-κB,简称p65)、p38 丝裂原活化蛋白激酶(p38 MAPK,简称p38)、细胞外信号调节激酶(ERK MAPK,简称ERK)蛋白磷酸化水平.体外实验中,采用 20 μg·mL-1 LPS刺激A549 细胞建立炎症模型,并给予橘红胎标准汤剂含药血清干预.噻唑蓝(MTT)法检测细胞活力;RT-qPCR检测细胞中TNF-α、IL-1β、IL-6、IL-18、TLR4、髓样分化因子 88(MyD88)、MMP9、CXC趋化因子配体 2(CXCL2)、IL-10 mRNA表达;Western blot检测IκB、p65、p38、ERK蛋白磷酸化水平.体内实验显示,橘红胎标准汤剂可降低肺组织W/D,减轻肺水肿;抑制MPO活性和NO水平,提高SOD活性,缓解氧化应激;HE染色显示,其显著改善LPS引起的肺泡结构破坏和炎症细胞浸润等病理变化,提高PAA评分;ELISA与RT-qPCR检测显示,其降低血清和肺组织促炎因子(TNF-α、IL-1β)含量及mRNA水平;免疫组化与Western blot检测显示,其抑制肺组织TLR4、MMP9 蛋白表达,下调IκB、p65、p38、ERK蛋白磷酸化水平.体外实验显示,橘红胎标准汤剂含药血清对A549 细胞活力的影响差异无统计学意义;RT-qPCR检测显示,其可显著降低细胞炎症因子(TNF-α、IL-1β、IL-6、IL-18、TLR4、MyD88、MMP9、CXCL2)mRNA水平,升高抗炎因子(IL-10)水平;Western blot检测显示,其同时下调IκB、p65、p38、ERK蛋白磷酸化水平.综上,橘红胎标准汤剂通过调控TLR4/MAPK/NF-κB信号通路,抑制炎症反应和氧化应激,从而缓解LPS诱导的ALI.

This study aimed to investigate the protective effect and mechanism of Juhongtai standard decoction(JSD)against lipopolysaccharide(LPS)-induced acute lung injury(ALI).In vivo,an ALI model was established using SD rats by intraperitoneal injection of LPS(5 mg·kg-1).The animals were randomly divided into six groups:control group,model group,dexamethasone(DEX,0.315 mg·kg-1)group,and low-,medium-,and high-dose JSD groups(0.787 5,1.575,and 3.15 g·kg-1,respectively).Wet/dry weight ratio(W/D),myeloperoxidase(MPO)activity,superoxide dismutase(SOD)activity in lung tissues,and nitric oxide(NO)levels in serum were measured.Pathological changes in lung tissue were observed by hematoxylin-eosin(HE)staining,and the percentage of alveolar area(PAA)was scored.Enzyme-linked immunosorbent assay(ELISA)and real-time quantitative polymerase chain reaction(RT-qPCR)were used to detect the content and mRNA expression of tumor necrosis factor(TNF)-α and interleukin(IL)-1β in serum and lung tissues.Immunohistochemistry and Western blot were employed to analyze the protein expression of Toll-like receptor 4(TLR4)and matrix metalloproteinase 9(MMP9),as well as the phosphorylation levels of inhibitor of nuclear factor-κB(IκB),p65,p38,and extracellular signal-regulated kinase(ERK).In vitro,A549 cells were stimulated with LPS(20 μg·mL-1)to establish an inflammation model and treated with JSD-containing serum.Cell viability was assessed by MTT assay.The mRNA expression of TNF-α,IL-1β,IL-6,IL-18,TLR4,myeloid differentiation factor 88(MyD88),MMP9,CXC chemokine ligand 2(CXCL2),and IL-10 was detected by RT-qPCR.Western blot was used to evaluate the phosphorylation of IκB,p65,p38,and ERK.The results showed that JSD significantly reduced the lung W/D ratio and alleviated pulmonary edema.It inhibited MPO activity and NO levels and enhanced SOD activity,which indicated the mitigation of oxidative stress.HE staining showed that it significantly ameliorated LPS-induced pathological changes,including alveolar structural destruction and inflammatory cell infiltration,and increased the PAA score.ELISA and RT-qPCR indicated that JSD decreased the levels and mRNA expression of pro-inflammatory cytokines such as TNF-α and IL-1β.Immunohistochemistry and Western blot revealed that JSD suppressed the protein expression of TLR4 and MMP9 and downregulated the phosphorylation of IκB,p65,p38 and ERK.In vitro,JSD-containing serum had no significant effect on cell viability but significantly reduced the mRNA expression of inflammatory factors(TNF-α,IL-1β,IL-6,IL-18,TLR4,MyD88,MMP9,and CXCL2)and increased the expression of the anti-inflammatory factor(IL-10).It also downregulated the phosphorylation of IκB,p65,p38 and ERK.In conclusion,JSD alleviates LPS-induced ALI by regulating the TLR4/MAPK/NF-κB signaling pathway and thereby suppressing inflammatory response and oxidative stress.

余婧婧;高泽林;陈昱帆;詹若挺;肖凤霞;邹宏庆;李佳玲;方家祺;黄凤萍;钟嘉锐;梁芳瑜;王雪华;麦宝愉

广州中医药大学 中药学院,广东 广州 510006华润三九医药股份有限公司,广东 深圳 518110广州中医药大学 中药学院,广东 广州 510006||广州中医药大学 岭南中药资源教育部重点实验室,广东 广州 510006广州中医药大学 中药学院,广东 广州 510006||广州中医药大学 岭南中药资源教育部重点实验室,广东 广州 510006广州中医药大学 中药学院,广东 广州 510006||广州中医药大学 岭南中药资源教育部重点实验室,广东 广州 510006广州中医药大学 中药学院,广东 广州 510006广州中医药大学 中药学院,广东 广州 510006北京中医药大学 深圳医院,广东 深圳 518172广州中医药大学 中药学院,广东 广州 510006广东粤和泽药物研究有限公司,广东 中山 528400广州中医药大学 中药学院,广东 广州 510006湛江科技学院 中医药学院,广东 湛江 524094香港中文大学 深圳研究院,广东 深圳 518057

化橘红橘红胎脂多糖急性肺损伤TLR4/MAPK/NF-κB信号通路炎症

Citri Grandis ExocarpiumJuhongtailipopolysaccharideacute lung injuryTLR4/MAPK/NF-κB signaling pathwayinflammation

《中国中药杂志》 2026 (11)

3049-3059,11

广东省教育厅普通高校重点领域专项(2022ZDZX4004)广州中医药大学创新创业培养计划项目(202410572293)2020年广东省农村科技特派员项目(KTP20200136)2024年省级乡村振兴战略专项资金种业振兴行动项目(2024-NPY-00-042)广东省现代农业产业技术体系创新团队建设项目(2026CXTD24)药事管理与法规专创融合课程项目(中药[2025]113号-18)

10.19540/j.cnki.cjcmm.20260212.502

评论